EUROPEAN ASSOCIATION FOR CANCER RESEARCH

Transcription

1 STATISTICS REPORT 23 rd Biennial Congress of the EUROPEAN ASSOCIATION FOR CANCER RESEARCH From Basic Research to Personalised Cancer Treatment German Cancer Society Experimental Cancer Research

2 Registration Type Invited Speakers 5% VIP, Guests and Media 3% 1426 Exhibitors and Industry 11% Delegates 81% (37% Students/Young Investigators) Students / Young Investigators Young Investigators 16% Students 84% Members / Non-members Members 49% Non-Members 51% Scientific Programme Related Statistics ABSTRACTS SUBMITTED: 932 ORAL PRESENTATIONS (BASED ON ABSTRACTS): 18 POSTER PRESENTATIONS: 796 NUMBER OF ORAL PRESENTATIONS (INVITED INCLUDED): 115 NUMBER OF SESSIONS: 30 2

3 Abstract Topics Cell and Tumour Biology 30% Experimental / Molecular Therapeutics, Pharmacogenomics 17% ABSTRACTS SUBMISSION Translational Research 14% Cancer Genomics, Epigenetics and Genomic Instability 11% Signaling Pathways 10% Molecular and Genetic Epidemiology 4% Carcinogenesis 4% Tumour Immunology 4% Radiobiology / Radiation Oncology 3% Prevention and Early Detection 3% Top 10 Abstract Submission by Country Top 10 Countries by Participation Germany 15% Germany 19% United Kindom 7% United Kingdom 10% Italy 7% Italy 6% ABSTRACTS/ COUNTRY Spain 6% 60 COUNTRIES France 6% Taiwan 5% Spain 5% France 5% USA 5% Portugal 4% Taiwan 4% Turkey 3% Australia 2% Australia 3% Norway 2% USA 3% Switzerland 2% Brazil 3% Others 39% Others 39% Continent Overview Europe 71% Asia 15% Americas 8% 1345 Middle East 3% Australia 2% Africa 1% 3

4 Place of Work University Hospital 36% University 16% 1516 Cancer Research Centre 15% Academia 10% Industry 8% Cancer Centre 5% Government 2% Non-profit Organisation 2% Pharma Industry 2% Hospital/Clinic 2% General Hospital 1% Contract Research Organisation <1% Private Practice <1% Regulatory Affairs <1% Regulatory Authorities <1% % of all delegates (excluding group registrations) 4

5 Profession Top 3 professions Basic Scientist 45% Student 27% Translational Scientist 12% Other professions Medical Oncologist 3% Geneticist 2% Lab Manager 2% Young Oncologist 1% Clinical Oncologist 1% Surgeon 1% Chemist 1% General Practitioner (GP) 1% Pharmacologist 1% Journalist <1% Medical Affairs <1% Lab Technician <1% Oncology Pharmacist <1% Clinical Pharmacist <1% Clinical Trial Coordinator <1% Haematologist <1% Radiation Oncologist <1% Statistician <1% Occupational Health <1% Community Pharmacist <1% Hospital Pharmacist <1% Nuclear Medicine <1% Nurse <1% % of all delegates (excluding group registrations) 5

6 App and Online Statistics iphone 36% ipad 18% TOTAL DOWNLOADS: 610 Android 46% Most popular sessions visited MECHANISMS OF DRUG RESISTANCE TUMOUR HETEROGENEITY OPENING CEREMONY / OPENING LECTURE THE TUMOUR MICROENVIRONMENT NOVEL CANCER THERAPIES 6

7 EACR23 Website pageviews TOTAL NUMBER OF PAGE VIEWS: UNIQUE USERS: #EACR23 TWEETS USING #EACR23: 729 TWITTER IMPRESSIONS: THE EACR23 CONGRESS SECRETARIAT: c/o ECCO the European CanCer Organisation Avenue E. Mounier 83 B-1200 Brussels Belgium Tel: Fax: eacr23@ecco-org.eu Website: 7

8 9 12 July 2016 Manchester, UK 24 th Biennial Congress of the European Association for Cancer Research From Basic Research to Precision Medicine Organised by SAVE THE DATE #EACR24 #EACR24 8